Russell Investments Group’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$806K Sell
34,353
-5,344
-13% -$130K ﹤0.01% 2569
2026
Q1
$954K Buy
39,697
+39,137
+6,989% +$1.02M ﹤0.01% 2235
2025
Q4
$11.8K Sell
560
-89
-14% -$937 ﹤0.01% 3755
2025
Q3
$6.46K Buy
649
+261
+67% +$2.95K ﹤0.01% 3857
2025
Q2
$3.52K Buy
388
+220
+131% +$2.09K ﹤0.01% 3513
2025
Q1
$1.6K Buy
+168
New +$2.04K ﹤0.01% 3548

Other funds holding GLSI

Russell Investments Group's GLSI Position: Q2 2026 in Review

Russell Investments Group reduced its Greenwich LifeSciences (GLSI) stake by 13% in Q2 2026, selling an estimated $130K and leaving 34,353 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #2569.

Russell Investments Group first reported a position in GLSI in Q1 2025 and has held it in 6 quarters since. The position peaked at $954K in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Russell Investments Group held 34,353 shares of Greenwich LifeSciences worth $806K as of Q2 2026.
  • Russell Investments Group sold 5,344 Greenwich LifeSciences shares in Q2 2026, an estimated $130K.
  • Greenwich LifeSciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2569 holding.
  • Russell Investments Group first reported a position in Greenwich LifeSciences in Q1 2025 and has held it in 6 quarters since.
  • Russell Investments Group's Greenwich LifeSciences position peaked at $954K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.